scorecardresearch
Add as a preferred source on Google
Saturday, January 3, 2026
TopicPharma industry

Topic: pharma industry

Chhindwara’s Coldrif deaths show India’s dangerous irony—pharmacy of the world, failing at home

India’s pharmaceutical sector is valued at $50 billion. It has built its reputation on affordability and accessibility. The deaths in Chhindwara tell a different story.

Indian drugmakers relieved but wary as US exempts pharma sector from new trade tariffs

Industry insiders say any rise in duties on Indian generics will squeeze profits for Indian companies, but will also make the drugs costlier for patients in US.

8 dead in Hyderabad pharma factory explosion, search & rescue ops ongoing

Telangana CM Reddy expressed his grief directing that all steps be taken to save the workers & provide them advanced medical care.

Don’t let foreign big pharma block biosimilars. Govt should boost access in India

Without widespread access to biosimilars, thousands of cancer patients are losing their battle. Life-saving treatment is not a privilege but a right. The government should understand this.

Alliance of India’s 26 top drugmakers opposes generic drug substitution at Janaushadhi Kendras

Leading drugmakers express apprehension over CDSCO’s proposal to permit generic alternatives for key medications, emphasizing the risk of compromised drug quality.

SubscriberWrites: Pharma industry – Yearning for reforms

Despite the critical importance of the Pharma Industry, no attempts were made to resolve the issues & transform the industry.

Import alerts, warning letters, drug recalls — why ‘pharmacy to the world’ is facing US FDA heat

New Delhi: On 18 April, Mumbai-headquartered Marksans Pharma, a drugmaker that supplies generic drugs in over 50 countries around the world, received form 483,...

Tirzepatide, another diabetes drug cleared for weight loss in US, yet to get regulator nod in India

In clinical trials, tirzepatide by Eli Lilly has shown to reduce body weight by up to 22.5 percent, on average, after about 72 weeks, according to the company.

No dent in Indian pharma exports despite quality concerns over cough syrups, data shows

WHO may be probing allegations of 20 substandard paracetamol & cough syrups by 15 manufacturers from India, but these allegations seem to have little impact on export of medicines.

Modi govt likely to bring in stricter pan-Indian system to recall substandard drugs from market

Provision included in draft bill to be approved by Union cabinet. Existing drugs law mentions product recall, but doesn't specify timelines or system for auditing and accountability.

On Camera

The Supreme Court is losing its credibility. It should frighten us all—Maneka Gandhi

The dogs will survive whatever orders are passed. But institutions are more fragile than we imagine. Once lost, the trust they embody takes generations to rebuild.

India’s urban co-op banks are turning the page—crisis to cautious revival, one metric at a time

With bad loans shrinking & capital buffers stronger, urban co-op banks’ new umbrella body NUCFDC is now prioritising rollout of digital transformation.

Greece looking at TATA’s WhAP infantry combat vehicle for army procurement

If deal goes through, Greece will be 2nd foreign country to procure vehicle. Morocco was first; TATA Group has set up manufacturing unit there with minimum 30 percent indigenous content.

A year-end Mea Culpa in National Interest—The Army-Islam combo doesn’t kill democracy

Many of you might think I got something so wrong in National Interest pieces written this year. I might disagree! But some deserve a Mea Culpa. I’d deal with the most recent this week.